As of Dec 02
| -0.0033 / -3.82%|
The 1 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +5,909.62% increase from the last price of 0.08.
The current consensus among 3 polled investment analysts is to Hold stock in Mast Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.